Paulo Bouça, BSc, Vice President Business Development
Mr. Paulo Bouça joined Reprobiogen in March 2022 as Vice President Business Development bringing with him over 25 years of international experience in fertility, business development, operations, sales, licensing, acquisitions, clinical development, research and medical devices.
Prior to joining Reprobiogen he held executive roles in several companies. Business Development VP for the Reproductive Health Division of Avrio Genetics and for 12 years the position of Chief Operating Officer and VP Business Development with Opmedic Group Inc., a group of fertility clinics and surgical services in Canada public traded on TSX.
He also worked as the General Manager & VP of Business Development for Adaltis and Biochem Immunosystems the diagnostic division of the public traded company Biochem Pharma, in charge of operations, sales, R&D and manufacturing of HIV, HTLV, HCV and hepatitis B kits.
Mr. Bouça started medical school in Lisbon, Portugal and completed his studies towards a BSc in Chemistry/Biochemistry at Concordia University in Montreal.